Microvascular Angina: Diagnosis and Management
Recognition of suspected ischaemia with no obstructive coronary artery disease – termed INOCA – has increased over the past decades, with a key contributor being microvascular angina. Patients with microvascular angina are at higher risk for major adverse cardiac events including MI, stroke, heart f...
Saved in:
| Main Authors: | Haider Aldiwani, Suzan Mahdai, Ghaith Alhatemi, C Noel Bairey Merz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-12-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2021.15 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updates on Pharmacologic Management of Microvascular Angina
by: Mosayeb Soleymani, et al.
Published: (2022-01-01) -
Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01) -
An Unusual Case of Suspected Microvascular Angina in a Newborn
by: Stefania Cataldo, et al.
Published: (2012-01-01) -
CLINICAL EFFECTIVENESS OF THE MODIFIED RELEASE TRIMETAZIDINE IN MICROVASCULAR ANGINA
by: P. Yu. Galin, et al.
Published: (2016-12-01) -
Myocardial biomarkers in coronary microvascular dysfunction: Response to ranolazine
by: Katherine E. Hampilos, et al.
Published: (2025-04-01)